Camlin Fine Sciences Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Los beneficios de Camlin Fine Sciences han disminuido a una tasa media anual de -44.2%, mientras que en la industria Chemicals los beneficios crecieron en un 14.6% anualmente. Los ingresos han ido creciendo a una tasa media de 11.1% al año.
Información clave
-44.2%
Tasa de crecimiento de los beneficios
-44.2%
Tasa de crecimiento del BPA
Crecimiento de la industria Chemicals | 17.7% |
Tasa de crecimiento de los ingresos | 11.1% |
Rentabilidad financiera | -37.1% |
Margen neto | -13.9% |
Última actualización de beneficios | 30 Sep 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb
Nov 27Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump
Mar 29Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?
Sep 02Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Apr 06Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic
Feb 19Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 17Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?
Oct 15Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jan 15Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture
Jan 04Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching
Nov 30Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Oct 05At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Aug 20Estimating The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jun 30Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26What Is Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Share Price Doing?
Feb 15Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Popular Amongst Insiders?
Feb 05Camlin Fine Sciences (NSE:CAMLINFINE) Shareholders Booked A 29% Gain In The Last Year
Jan 26Here's What To Make Of Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Jan 16Don't Ignore The Fact That This Insider Just Sold Some Shares In Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jan 06Should You Be Adding Camlin Fine Sciences (NSE:CAMLINFINE) To Your Watchlist Today?
Jan 04Can Mixed Fundamentals Have A Negative Impact on Camlin Fine Sciences Limited (NSE:CAMLINFINE) Current Share Price Momentum?
Dec 24How Should Investors React To Camlin Fine Sciences' (NSE:CAMLINFINE) CEO Pay?
Dec 13Does Camlin Fine Sciences's (NSE:CAMLINFINE) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 02Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Nov 21Is Now An Opportune Moment To Examine Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Nov 09The Camlin Fine Sciences (NSE:CAMLINFINE) Share Price Is Up 49% And Shareholders Are Holding On
Oct 27What Do The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Tell Us?
Oct 14Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 29% Price Boost Is Out Of Tune With Earnings
Oct 01Here's Why I Think Camlin Fine Sciences (NSE:CAMLINFINE) Might Deserve Your Attention Today
Sep 30What Kind Of Shareholders Hold The Majority In Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Shares?
Sep 17Read This Before Judging Camlin Fine Sciences Limited's (NSE:CAMLINFINE) ROE
Sep 04Desglose de ingresos y gastos
Cómo gana y gasta dinero Camlin Fine Sciences. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Sep 24 | 16,064 | -2,231 | 2,406 | 0 |
30 Jun 24 | 15,893 | -1,423 | 2,315 | 0 |
31 Mar 24 | 16,131 | -928 | 2,242 | 0 |
31 Dec 23 | 16,381 | -8 | 1,931 | 0 |
30 Sep 23 | 16,400 | 350 | 1,893 | 0 |
30 Jun 23 | 17,174 | 674 | 1,850 | 0 |
31 Mar 23 | 16,816 | 577 | 1,823 | 0 |
31 Dec 22 | 16,441 | 581 | 1,727 | 0 |
30 Sep 22 | 16,371 | 628 | 1,710 | 0 |
30 Jun 22 | 14,650 | 442 | 1,666 | 0 |
31 Mar 22 | 14,121 | 650 | 1,582 | 0 |
31 Dec 21 | 13,495 | 598 | 1,521 | 0 |
30 Sep 21 | 12,666 | 465 | 1,436 | 0 |
30 Jun 21 | 12,122 | 579 | 1,375 | 0 |
31 Mar 21 | 11,871 | 510 | 1,301 | 0 |
31 Dec 20 | 11,533 | 394 | 1,312 | 0 |
30 Sep 20 | 11,293 | 291 | 1,255 | 0 |
30 Jun 20 | 10,948 | 302 | 1,207 | 0 |
31 Mar 20 | 10,491 | 303 | 1,180 | 0 |
31 Dec 19 | 10,243 | 349 | 1,170 | 0 |
30 Sep 19 | 9,918 | 277 | 1,139 | 0 |
30 Jun 19 | 9,709 | 221 | 1,121 | 0 |
31 Mar 19 | 8,922 | 6 | 1,092 | 0 |
31 Dec 18 | 8,523 | -139 | 1,053 | 0 |
30 Sep 18 | 8,186 | -222 | 1,016 | 0 |
30 Jun 18 | 7,634 | -277 | 969 | 0 |
31 Mar 18 | 7,206 | -338 | 935 | 0 |
31 Dec 17 | 6,403 | -367 | 865 | 20 |
30 Sep 17 | 5,676 | -311 | 843 | 20 |
30 Jun 17 | 5,347 | -275 | 820 | 22 |
31 Mar 17 | 5,339 | -128 | 820 | 0 |
31 Dec 16 | 5,149 | 98 | 737 | 21 |
30 Sep 16 | 5,013 | 174 | 649 | 21 |
30 Jun 16 | 5,063 | 232 | 496 | 21 |
31 Mar 16 | 4,893 | 358 | 562 | 21 |
31 Dec 15 | 5,083 | 445 | 879 | 25 |
30 Sep 15 | 5,238 | 463 | 906 | 25 |
30 Jun 15 | 5,531 | 552 | 883 | 25 |
31 Mar 15 | 5,583 | 550 | 516 | 25 |
31 Mar 14 | 5,087 | 287 | 344 | 27 |
Ingresos de calidad: CAMLINFINE actualmente no es rentable.
Margen de beneficios creciente: CAMLINFINE actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: CAMLINFINE no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 44.2% al año.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de CAMLINFINE en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: CAMLINFINE no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (8%).
Rentabilidad financiera
Alta ROE: CAMLINFINE tiene una rentabilidad financiera negativa (-37.1%), ya que actualmente no es rentable.